secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2025-09-29T23:59:59+00:00
Accession:  0001477932-25-007111
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health CEO letter details $300M digital asset facility, H1 revenue up 11.7%, 2027 guidance
--------------------------------------------------------------------------------

- Secured $300M senior secured convertible note; 72.5% net proceeds to digital treasury (ETH, BTC, SOL).
- H1 2025 revenue $28.46M (+11.7% YoY); gross profit $3.21M (+53%).
- 2024 revenue $54.43M (+2%); net loss ($4.74M); adjusted EBITDA ($3.73M).
- 2027 targets: revenue ~$155.8M, adj. EBITDA ~$29.4M, positive operating cash flow.
- Sky Premium Life expanded to US, UAE, Qatar, Central Europe; now 150+ SKUs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793225007111/0001477932-25-007111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793225007111/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-007111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer